Trademark: THE BRAIN CANCER CENTRE MANY MINDS. ONE FOCUS. FOUNDED BY CARRIE'S BEANIES 4 BRAIN CANCER 2222659
Word
THE BRAIN CANCER CENTRE MANY MINDS. ONE FOCUS. FOUNDED BY CARRIE'S BEANIES 4 BRAIN CANCER
Device Descrption:
BRAINS,STYLISED FORM QUOTATION-BALLOON ATOP LTR I
ID
2222659
Trademark Type
Figurative
Status
Lapsed: Not accepted
Application Date
25 October 2021
Owner(s)
Service
FB Rice Pty Ltd
Goods and Services:
Class 41:
Education; provision of training and further education specifically in the field of scientific and medical research
Education; provision of training and further education specifically in the field of scientific and medical research
Class 42:
The provision of services in respect of medical and scientific research; research and development; medical research; pharmaceutical research; diagnostic research and development; consulting and reporting in the fields of medical and pharmaceutical research; research and development services including in relation to development of programmes for the treatment of diseases including cancer, development and ageing, and immune health and infection; research and development in the field of bioinformatics, cancer biology, cell death, cell signalling, clinical translation, colony stimulating factors, computational biology, epigenetics, haematology, immunology, immunotherapy, infection, inflammation, personalised medicine, stem cells, systems biology; research and development in the field of antibody technologies, drug discovery, flow cytometry, genomics, imaging, medicinal chemistry, proteomics, structural biology, and vaccine development; provision of information in relation to the foregoing
The provision of services in respect of medical and scientific research; research and development; medical research; pharmaceutical research; diagnostic research and development; consulting and reporting in the fields of medical and pharmaceutical research; research and development services including in relation to development of programmes for the treatment of diseases including cancer, development and ageing, and immune health and infection; research and development in the field of bioinformatics, cancer biology, cell death, cell signalling, clinical translation, colony stimulating factors, computational biology, epigenetics, haematology, immunology, immunotherapy, infection, inflammation, personalised medicine, stem cells, systems biology; research and development in the field of antibody technologies, drug discovery, flow cytometry, genomics, imaging, medicinal chemistry, proteomics, structural biology, and vaccine development; provision of information in relation to the foregoing